BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2019
View Archived Issues
Inhibition of cystine/glutamate antiporter system Xc- identified as a possible target for epilepsy
Read More
Risk assessment for long QT syndrome
Read More
Mapping microbial metabolites to GPCRs
Read More
Phase II data for unadjuvanted subvirion monovalent inactivated influenza H3N2v vaccine
Read More
Syros Pharmaceuticals presents new CDK7/cyclin H inhibitors
Read More
Novel M4 positive allosteric modulator with improved physicochemical properties and favorable PK
Read More
Elicio presents preclinical data for ELI-002 vaccine targeting KRAS-driven cancers
Read More
APOC1 as a novel diagnostic and prognostic biomarker for gastric cancer
Read More
ZL-0580: a novel BRD4-selective small molecule that suppresses HIV
Read More
89bio initiates phase Ib/IIa study of BIO89-100 for the treatment of NASH
Read More
DPS-2: A dual MEK/ERK and PI3K/AKT inhibitor developed for colorectal cancer
Read More
First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279
Read More
Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25%
Read More
TaiGen Biotechnology presents influenza cap-dependent endonuclease inhibitors
Read More
Immuron reports data from TREAT-003 study of IMM-124-E in severe alcoholic hepatitis
Read More
New selective estrogen receptor modulators disclosed by Radius Pharmaceuticals
Read More
Sesen Bio presents developmental update for Vicinium
Read More
NIH awards major grant to ImmunogenX to conduct phase II study for latiglutenase
Read More
Hemispherx reports positive safety and survival data from phase I study of Ampligen
Read More
New liver cell discovery may enable hepatic regeneration
Read More
Starpharma initiates phase I/II study of DEP irinotecan
Read More
Phase IIb/III THEIA-1 study of TOP-1630 does not meet primary endpoints
Read More
FDA accepts Agenus' AGEN-2373 IND filing
Read More
